Journey Clinical is a leading platform for Psychedelic-Assisted Psychotherapy (PAP) in the United States, featuring the largest network of licensed therapists in this field. Founded by Jonathan Sabbagh and Myriam Barthes, the company aims to enhance access to safe and effective psychedelic treatments for individuals facing mental health challenges. The inspiration behind the company stems from Sabbagh’s personal experience with psychedelic therapies, particularly ketamine-assisted psychotherapy.

The company operates a collaborative care model that connects medical teams, licensed psychotherapists, and patients. This model enables therapists to integrate psychedelic therapies into their practices with the necessary tools and support. Journey Clinical provides patients with access to a qualified medical team for evaluation and ongoing care, ensuring safety throughout their treatment. Since its launch in February 2022, Journey Clinical has rapidly expanded, growing its network of KAP therapists and treating over 1,000 patients nationwide. The company emphasizes patient safety and aims to improve clinical outcomes through its rigorous policies and procedures.